Dual antiplatelet therapy after coronary stenting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual antiplatelet therapy after coronary stenting

Published:2016-06-28 Issue:13 Volume:17 Page:1775-1787
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Park Yongwhi¹²,Franchi Francesco¹,Rollini Fabiana¹,Angiolillo Dominick J¹

Affiliation:

1. Division of Cardiology, University of Florida College of Medicine – Jacksonville, Jacksonville, FL, USA

2. Department of Internal Medicine, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Korea

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2016.1202924

Reference72 articles.

1. The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes

2. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

3. 2014 ESC/EACTS Guidelines on myocardial revascularization

4. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

5. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack;Journal of Atherosclerosis and Thrombosis;2023

2. Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations;Expert Review of Clinical Pharmacology;2021-05-26

3. Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions;Expert Opinion on Drug Safety;2020-11-30

4. Clinical benefits of prolonged dual antiplatelet therapy following complex percutaneous coronary intervention;Coronary Artery Disease;2020-05

5. Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial;Trials;2020-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3